Trials / Completed

CompletedNCT00239070

Extension Study on the Safety and Efficacy of Enteric-coated Mycophenolate Sodium in Kidney Transplant Recipients

A Prospective, Open-label, Multicenter, International Follow-up Study on the Safety and Efficacy of Enteric-coated Mycophenolate Sodium (EC-MPS) in Kidney Transplant Recipients

Status: Completed
Phase: Phase 3
Study type: Interventional
Enrollment: 69 (actual)

Sponsor: Novartis · Industry
Sex: All
Age: 18 Years – 75 Years
Healthy volunteers: —

Summary

This extension study is to assess the long-term safety of EC-MPS

Conditions

Renal Transplantation

Interventions

Type	Name	Description
DRUG	Enteric-Coated Mycophenolate Sodium (EC-MPS)

Timeline

Start date: 2003-04-01
Primary completion: 2006-05-01
Completion: 2006-05-01
First posted: 2005-10-14
Last updated: 2011-01-31

Source: ClinicalTrials.gov record NCT00239070. Inclusion in this directory is not an endorsement.